Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B1448 vs Alteplase in Acute Pulmonary Embolism (Phase IIa)
CTR20160936Phase 2Completed
- Sponsor
- Shanghai Tasly Biopharmaceutical
- Start
- Mar 2017
- Modality
- Metabolic Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human prourokinase in pulmonary embolism (PE), sponsored by Shanghai Tasly Biopharmaceutical. Started Mar 2017; status: completed.
02
Drugs
recombinant human prourokinase
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on CTR20160936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160936.